Xi Ding

729 total citations
23 papers, 313 citations indexed

About

Xi Ding is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Xi Ding has authored 23 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Otorhinolaryngology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Xi Ding's work include Head and Neck Cancer Studies (11 papers), Thyroid Disorders and Treatments (6 papers) and Head and Neck Surgical Oncology (5 papers). Xi Ding is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Thyroid Disorders and Treatments (6 papers) and Head and Neck Surgical Oncology (5 papers). Xi Ding collaborates with scholars based in China. Xi Ding's co-authors include Mingqian He, Jinzhong Min, Ziyi Chen, Zhiping Wen, Naigeng Wu, Guixing Chen, Zhiyong Meng, Yue Wang, Bingyin Shi and Liping Wu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Surgical Oncology.

In The Last Decade

Xi Ding

21 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xi Ding China 10 71 67 63 59 52 23 313
Lan Lin China 10 10 0.1× 27 0.4× 12 0.2× 107 1.8× 28 0.5× 30 268
Yuejiao Zhao China 12 58 0.8× 13 0.2× 9 0.1× 30 0.5× 69 1.3× 20 332
Youfang Chen China 14 9 0.1× 17 0.3× 11 0.2× 90 1.5× 19 0.4× 46 580
Wen-Wei Xu China 5 93 1.3× 46 0.7× 30 0.5× 40 0.7× 7 335
Lill T. Norvang Nilsen Norway 12 37 0.5× 20 0.3× 20 0.3× 54 0.9× 27 404
Andre Burnier United States 8 177 2.5× 42 0.6× 21 0.3× 52 0.9× 9 456
Antonio García‐Méndez Spain 8 16 0.2× 147 2.2× 144 2.3× 17 0.3× 21 393
Jonathan Baker United Kingdom 8 167 2.4× 43 0.6× 44 0.7× 8 0.1× 12 438
Yanhui Xie China 13 4 0.1× 87 1.3× 77 1.2× 40 0.7× 2 0.0× 36 403
Anne Lenz United States 7 91 1.3× 27 0.4× 26 0.4× 43 0.7× 15 267

Countries citing papers authored by Xi Ding

Since Specialization
Citations

This map shows the geographic impact of Xi Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Ding more than expected).

Fields of papers citing papers by Xi Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Ding. The network helps show where Xi Ding may publish in the future.

Co-authorship network of co-authors of Xi Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Ding. A scholar is included among the top collaborators of Xi Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Ding. Xi Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, You‐Ping, Haibo Wu, Jianzhong Zhang, et al.. (2025). Endoscopic Transoropharyngeal Retropharyngeal Lymph Node (RPLN) Dissection for RPLN Recurrence Nasopharyngeal Carcinoma. Annals of Surgical Oncology. 32(12). 9179–9187. 1 indexed citations
2.
Ding, Xi, et al.. (2025). The association between life satisfaction, depressive symptoms, and common comorbid disorders during the COVID‐19 pandemic. Applied Psychology Health and Well-Being. 17(3). e70035–e70035.
3.
Wang, Sophia, Zimeng Wang, Sihan Liu, et al.. (2024). Lachnoclostridium intestinal flora is associated with immunotherapy efficacy in nasopharyngeal carcinoma. Head & Neck. 47(1). 269–281. 4 indexed citations
4.
5.
Ding, Xi, et al.. (2024). Characteristics and treatment of epistaxis in nasopharyngeal carcinoma. Oral Oncology. 159. 107071–107071. 2 indexed citations
6.
Ding, Xi, Yi‐Jun Hua, Xiong Zou, et al.. (2023). Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 study. EClinicalMedicine. 61. 102043–102043. 8 indexed citations
7.
Ding, Xi, Weijing Zhang, Rui You, et al.. (2023). Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study. Journal of Clinical Oncology. 41(14). 2571–2582. 38 indexed citations
8.
Zou, Xiong, Yi‐Jun Hua, You‐Ping Liu, et al.. (2023). A novel endoscopic nasopharyngectomy by low‐temperature plasma radiofrequency ablation in localized recurrent nasopharyngeal carcinoma. Head & Neck. 46(2). 291–299. 1 indexed citations
9.
Zhao, Yang, et al.. (2022). A New Way Out of the Predicament of Anaplastic Thyroid Carcinoma From Existing Data Analysis. Frontiers in Endocrinology. 13. 887906–887906. 2 indexed citations
10.
You, Rui, Xiong Zou, Xi Ding, et al.. (2022). Gemcitabine combined with apatinib and toripalimab in recurrent or metastatic nasopharyngeal carcinoma. Med. 3(10). 664–681.e6. 12 indexed citations
11.
Ding, Xi, Rui Li, Liping Wu, et al.. (2021). Lower normal free thyroxine is associated with a higher risk of metabolic syndrome: a retrospective cohort on Chinese population. BMC Endocrine Disorders. 21(1). 39–39. 6 indexed citations
12.
Ding, Xi, You‐Ping Liu, Yi‐Jun Hua, et al.. (2021). Clinical advances in nasopharyngeal carcinoma surgery and a video demonstration. SHILAP Revista de lepidopterología. 2. 2–2. 4 indexed citations
13.
Ding, Xi, Yang Zhao, Liping Wu, et al.. (2021). The association between subclinical hypothyroidism and metabolic syndrome: an update meta-analysis of observational studies. Endocrine Journal. 68(9). 1043–1056. 29 indexed citations
14.
Liu, You‐Ping, Xi Ding, Rui You, et al.. (2021). Endoscopic nasopharyngectomy in nasopharyngeal carcinoma. Operative Techniques in Otolaryngology-Head and Neck Surgery. 32(1). 52–60. 1 indexed citations
15.
Zhang, Meng, Xi Ding, Liping Wu, et al.. (2020). A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit. Thyroid. 31(4). 638–648. 28 indexed citations
16.
He, Mingqian, Yue Wang, Jing Sui, et al.. (2020). The potential markers involved in newly diagnosed graves' disease and the development of active graves' orbitopathy. Cytokine. 127. 154998–154998. 9 indexed citations
17.
Chen, Ziyi, Yue Wang, Xi Ding, et al.. (2019). The proportion of peripheral blood Tregs among the CD4+ T cells of autoimmune thyroid disease patients: a meta-analysis. Endocrine Journal. 67(3). 317–326. 23 indexed citations
18.
Wu, Naigeng, Xi Ding, Zhiping Wen, et al.. (2019). Contrasting frontal and warm-sector heavy rainfalls over South China during the early-summer rainy season. Atmospheric Research. 235. 104693–104693. 80 indexed citations
20.
Ding, Xi, et al.. (2009). [Infections of the head and neck leading to descending necrotizing mediastinitis: management of 9 cases].. PubMed. 44(10). 619–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026